Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00443677
Status:
COMPLETED
Last Update Posted:
2009-03-20
First Post:
2007-03-05
Brief Title:
Treatment of Advanced Hodgkins Disease Stages IIB-III-IV
Sponsor:
Gruppo Italiano Studio Linfomi
Organization:
Gruppo Italiano Studio Linfomi
Study Overview
Official Title:
Treatment of Advanced Hodgkins Disease Stages IIB-III-IV
Status:
COMPLETED
Status Verified Date:
2009-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HD2000
Brief Summary:
The purpose of this study is to compare the toxicities of the COPPEBVCAD vs BEACOPP vs ABVD regimens
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None